Download PDF
Thromb Haemost 1975; 34(03): 648-651
DOI: 10.1055/s-0038-1651455
Original Article
Schattauer GmbH

Short-Term Enhancement of Plasminogen Activator in Vivo by Drugs[*]

J. D Cash
1   S-E Scotland Regional Blood Transfusion Centre, Royal Infirmary, Edinburgh EH3 9HB, Scotland
› Author Affiliations
Further Information

Publication History

Received 01 July 1975

Accepted 01 July 1975

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

* Presented at the Postgraduate Course and Workshop “Progress in Fibrinolysis”, Milan, March 6–8, 1975.


 

  • References

  • 1 Ahlquist R. P. 1948; The study of adrenotropic receptors. American Journal of Physiology 153: 586.
    PubMedGoogle Scholar
  • 2 Ambry A, Vermylen J, De Vreker R. A, Vermylen C, and Verstraete M. 1965; Enhancing blood fibrinolytic activity by a Niacin compound. American Journal of the Medical Sciences 249: 66.
    CrossrefPubMedGoogle Scholar
  • 3 Amery A, Vbemylen J, and Verstraete M. 1966; Enhancing blood fibrinolytic activity by a Niacin compound. Scandinavian Journal of Haematology 3: 76.
    PubMedGoogle Scholar
  • 4 Andersson K. E, Arner B, Furst E, and Hedner P. 1974; Antidiuretic responses to hypertonic saline infusion, water deprivation, and a synthetic analogue of vasopressin in patients with hereditary, hypothalamic diabetes insipidus. Acta medica Scandinavica 195: 17.
    PubMedGoogle Scholar
  • 5 Brittain R. T, Jack D, and Ritchie A. C. 1970; Recent β-adrenoreceptor stimulants. Advances in Drug Research 5: 197.
    PubMedGoogle Scholar
  • 6 Cash J. D. 1972. Platelets, fibrinolysis and stress. In: Brinkhous K. (ed.) Thrombosis: Risk Factors and Diagnostic Approaches. Schattauer Verlag; Stuttgart-New York: 93
    Google Scholar
  • 7 Cash J. D, Gader A. M. A, and de Costa J. 1974; The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, l-desimino-8-d-arginine vasopressin angiotensin and oxytocin in man. British Journal of Haematology 27: 363.
    PubMedGoogle Scholar
  • 8 Cash J. D, Woodfleld D. G, and Allan A. G. E. 1970; Adrenergic mechanisms in the systemic plasminogen activator response to adrenaline in man. British Journal of Haematology 18: 487.
    CrossrefPubMedGoogle Scholar
  • 9 Fitzgerald J. D. 1969; Perspectives in adrenergic beta-receptor blockade. Clinical Pharmacology and Therapeutics 10: 292.
    PubMedGoogle Scholar
  • 10 Gader A. M. A, Clarkson A. R, and Cash J. D. 1973; a The plasminogen activator and coagulation factor VIII responses to adrenaline, noradrenaline, isoprenaline and salbutamol in man. Thrombosis Besearch 2: 9.
    PubMedGoogle Scholar
  • 11 Gader A. M. A, da Costa J, and Cash J. D. 1973; b A new vasopressin analogue and fibrinolysis. Lancet 2: 1417.
    PubMedGoogle Scholar
  • 12 Gader A. M. A, da Costa J, and Cash J. D. 1974; a The effect of propranolol, alprenolol and practolol on the fibrinolytic and factor VIII responses to adrenaline and salbutamol in man. Thrombosis Besearch 4: 25.
    PubMedGoogle Scholar
  • 00 Gader A. M. A, Parker S, Crompton G, and Cash J. D. 1973; c Fibrinolytic, factor VIII and pulse rate responses to intravenous adrenaline during chronic oral salbutamol administration. Thrombosis Besearch 3: 137.
    PubMedGoogle Scholar
  • 13 Genton E, Kern F, and von Kaulla K. 1961; Fibrinolysis induced by pressor amines. American Journal of Medicine 31: 564.
    CrossrefPubMedGoogle Scholar
  • 14 Huguenin B. L, and Boissonas B. A. 1966; Synthese de la desamino-1Arg8-vaso-pressine et de la desamino-1-Phe2-Arg8-vasopressine, deux analogues possédant une activité antidiuretique plus élevée et plus selective que celle des vasopressines naturelles. Helvetica Chimica Acta (Basel) 49: 695.
    CrossrefPubMedGoogle Scholar
  • 15 Macfarlane B. G, and Biggs B. 1946; Observations on fibrinolysis. Spontaneous activity associated with surgical operations, trauma etc. Lancet 2: 862.
    PubMedGoogle Scholar
  • 16 McNicol G. P, and Douglas A. S. 1965; Studies with complamin, a Nicotinic-acid-Theophylline Ester, as a fibrinolytic agent. British Medical Journal 1: 1149.
    CrossrefPubMedGoogle Scholar
  • 17 Mannucci P, and Barbi G. L. 1973. Abstract: VIIth Annual Meeting of the European Society of Clinical Investigation. Rotterdam: 144.
    Google Scholar
  • 18 Meneghini P, and Piccinini F. 1958; Attivazione fibrinolilhca del sangue da acido e da alcool nicotinica. Archivio e Maragliano di Patologiae Clinica 14: 69.
    PubMedGoogle Scholar
  • 19 Schneck S. A, and von Kaulla K. N. 1961; Fibrinolysis and the nervous system. Neurology 11: 959.
    CrossrefPubMedGoogle Scholar
  • 21 Tanser A. R, and Smellie H. 1964; Observations on adrenaline induced fibrinolysis in man. Clinical Science 26: 375.
    PubMedGoogle Scholar
  • 22 Vermylen J, Fierens F, De Vreker R. A, and Verstraete M. 1966; The activation of fibrinolysis with 3-Pyridil-acetic acid. Acta Haematologica 35: 91.
    CrossrefPubMedGoogle Scholar
  • 23 Weiner M, De Crinis K, Redisch K, and Steele J. M. 1959; Influence of some vasoactive drugs on fibrinolytic activity. Circulation 19: 845.
    CrossrefPubMedGoogle Scholar
  • 24 Weiner M, Redisch W, and Steele J. M. 1958; Occurrence of fibrinolytic activity following administration of nicotinic acid. Proceedings of the Society for Experimental Biology and Medicine (N.Y.) 98: 755.
    PubMedGoogle Scholar
  • 25 Zaoral M, and Kok J. 1967; Amino acids and peptides, LXXI. Synthesis of 1-desamino-8-d-aminobutyrine-vasopressin, l-desamino-8-d-lysine vasopressin and l-desamino-8-d-arginine-vasopressin. Collection of Czechoslovak chemical communications 32: 1250.
    CrossrefPubMedGoogle Scholar